nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—bile—Crohn's disease	0.0621	0.349	CbGeAlD
Disopyramide—CHRM3—muscle of abdomen—Crohn's disease	0.0569	0.32	CbGeAlD
Disopyramide—Lupus erythematosus—Mesalazine—Crohn's disease	0.0226	0.0443	CcSEcCtD
Disopyramide—Rash generalised—Mesalazine—Crohn's disease	0.0198	0.0388	CcSEcCtD
Disopyramide—Ache—Mesalazine—Crohn's disease	0.0182	0.0358	CcSEcCtD
Disopyramide—Abdominal bloating—Mesalazine—Crohn's disease	0.0177	0.0347	CcSEcCtD
Disopyramide—ORM1—gall bladder—Crohn's disease	0.0172	0.0969	CbGeAlD
Disopyramide—Systemic lupus erythematosus—Mesalazine—Crohn's disease	0.0152	0.0298	CcSEcCtD
Disopyramide—Feeling hot—Mesalazine—Crohn's disease	0.0107	0.021	CcSEcCtD
Disopyramide—Jaundice cholestatic—Azathioprine—Crohn's disease	0.0105	0.0206	CcSEcCtD
Disopyramide—Jaundice cholestatic—Mesalazine—Crohn's disease	0.00958	0.0188	CcSEcCtD
Disopyramide—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.0089	0.0175	CcSEcCtD
Disopyramide—SLC22A2—digestive system—Crohn's disease	0.00879	0.0494	CbGeAlD
Disopyramide—Blood urea increased—Mesalazine—Crohn's disease	0.00795	0.0156	CcSEcCtD
Disopyramide—Dry eye—Mesalazine—Crohn's disease	0.00777	0.0152	CcSEcCtD
Disopyramide—Coma—Mesalazine—Crohn's disease	0.00769	0.0151	CcSEcCtD
Disopyramide—SCN5A—digestive system—Crohn's disease	0.00743	0.0418	CbGeAlD
Disopyramide—KCND3—lymph node—Crohn's disease	0.00707	0.0397	CbGeAlD
Disopyramide—CHRM3—smooth muscle tissue—Crohn's disease	0.00652	0.0367	CbGeAlD
Disopyramide—Blood creatinine increased—Mesalazine—Crohn's disease	0.00572	0.0112	CcSEcCtD
Disopyramide—Abdominal pain upper—Mesalazine—Crohn's disease	0.00558	0.0109	CcSEcCtD
Disopyramide—Oedema—Mercaptopurine—Crohn's disease	0.00553	0.0109	CcSEcCtD
Disopyramide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00542	0.0106	CcSEcCtD
Disopyramide—Skin disorder—Mercaptopurine—Crohn's disease	0.00537	0.0105	CcSEcCtD
Disopyramide—Abdominal distension—Mesalazine—Crohn's disease	0.00532	0.0104	CcSEcCtD
Disopyramide—Anorexia—Mercaptopurine—Crohn's disease	0.00527	0.0103	CcSEcCtD
Disopyramide—CHRM3—digestive system—Crohn's disease	0.00515	0.029	CbGeAlD
Disopyramide—Dysuria—Mesalazine—Crohn's disease	0.00494	0.00968	CcSEcCtD
Disopyramide—Neutropenia—Mesalazine—Crohn's disease	0.00494	0.00968	CcSEcCtD
Disopyramide—Pollakiuria—Mesalazine—Crohn's disease	0.00488	0.00957	CcSEcCtD
Disopyramide—Agranulocytosis—Azathioprine—Crohn's disease	0.00482	0.00946	CcSEcCtD
Disopyramide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00481	0.00943	CcSEcCtD
Disopyramide—Weight increased—Mesalazine—Crohn's disease	0.00481	0.00943	CcSEcCtD
Disopyramide—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00471	0.00923	CcSEcCtD
Disopyramide—Depression—Mesalazine—Crohn's disease	0.00469	0.00921	CcSEcCtD
Disopyramide—Agranulocytosis—Mesalazine—Crohn's disease	0.00439	0.00862	CcSEcCtD
Disopyramide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00437	0.00858	CcSEcCtD
Disopyramide—Hepatitis—Mesalazine—Crohn's disease	0.00423	0.00829	CcSEcCtD
Disopyramide—Arrhythmia—Azathioprine—Crohn's disease	0.00414	0.00813	CcSEcCtD
Disopyramide—ORM1—lymph node—Crohn's disease	0.00387	0.0218	CbGeAlD
Disopyramide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00379	0.00743	CcSEcCtD
Disopyramide—Ill-defined disorder—Azathioprine—Crohn's disease	0.00375	0.00735	CcSEcCtD
Disopyramide—Malaise—Azathioprine—Crohn's disease	0.00364	0.00714	CcSEcCtD
Disopyramide—Flatulence—Mesalazine—Crohn's disease	0.00363	0.00711	CcSEcCtD
Disopyramide—Tension—Mesalazine—Crohn's disease	0.00361	0.00708	CcSEcCtD
Disopyramide—Dysgeusia—Mesalazine—Crohn's disease	0.0036	0.00707	CcSEcCtD
Disopyramide—Nervousness—Mesalazine—Crohn's disease	0.00357	0.00701	CcSEcCtD
Disopyramide—Cardiac failure congestive—Prednisone—Crohn's disease	0.00356	0.00699	CcSEcCtD
Disopyramide—Vomiting—Mercaptopurine—Crohn's disease	0.00352	0.0069	CcSEcCtD
Disopyramide—Rash—Mercaptopurine—Crohn's disease	0.00349	0.00684	CcSEcCtD
Disopyramide—Dermatitis—Mercaptopurine—Crohn's disease	0.00349	0.00684	CcSEcCtD
Disopyramide—Vision blurred—Mesalazine—Crohn's disease	0.00347	0.0068	CcSEcCtD
Disopyramide—Ill-defined disorder—Mesalazine—Crohn's disease	0.00341	0.0067	CcSEcCtD
Disopyramide—Discomfort—Azathioprine—Crohn's disease	0.0034	0.00666	CcSEcCtD
Disopyramide—Angioedema—Mesalazine—Crohn's disease	0.00336	0.00659	CcSEcCtD
Disopyramide—Malaise—Mesalazine—Crohn's disease	0.00332	0.00651	CcSEcCtD
Disopyramide—Cardiac failure—Prednisone—Crohn's disease	0.00331	0.0065	CcSEcCtD
Disopyramide—Vertigo—Mesalazine—Crohn's disease	0.00331	0.00648	CcSEcCtD
Disopyramide—Syncope—Mesalazine—Crohn's disease	0.0033	0.00647	CcSEcCtD
Disopyramide—Nausea—Mercaptopurine—Crohn's disease	0.00329	0.00645	CcSEcCtD
Disopyramide—Loss of consciousness—Mesalazine—Crohn's disease	0.00323	0.00634	CcSEcCtD
Disopyramide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00323	0.00633	CcSEcCtD
Disopyramide—Skin disorder—Azathioprine—Crohn's disease	0.0032	0.00628	CcSEcCtD
Disopyramide—Psychotic disorder—Prednisone—Crohn's disease	0.00316	0.00619	CcSEcCtD
Disopyramide—Chest pain—Mesalazine—Crohn's disease	0.00313	0.00614	CcSEcCtD
Disopyramide—Discomfort—Mesalazine—Crohn's disease	0.00309	0.00607	CcSEcCtD
Disopyramide—Hypotension—Azathioprine—Crohn's disease	0.00308	0.00604	CcSEcCtD
Disopyramide—Cardiac arrest—Prednisone—Crohn's disease	0.00307	0.00603	CcSEcCtD
Disopyramide—Dry mouth—Mesalazine—Crohn's disease	0.00306	0.00601	CcSEcCtD
Disopyramide—Confusional state—Mesalazine—Crohn's disease	0.00303	0.00594	CcSEcCtD
Disopyramide—Oedema—Mesalazine—Crohn's disease	0.003	0.00589	CcSEcCtD
Disopyramide—Shock—Mesalazine—Crohn's disease	0.00295	0.00579	CcSEcCtD
Disopyramide—Hypokalaemia—Prednisone—Crohn's disease	0.00294	0.00577	CcSEcCtD
Disopyramide—Thrombocytopenia—Mesalazine—Crohn's disease	0.00294	0.00577	CcSEcCtD
Disopyramide—Skin disorder—Mesalazine—Crohn's disease	0.00292	0.00572	CcSEcCtD
Disopyramide—Hyperhidrosis—Mesalazine—Crohn's disease	0.0029	0.00569	CcSEcCtD
Disopyramide—Anorexia—Mesalazine—Crohn's disease	0.00286	0.00561	CcSEcCtD
Disopyramide—Muscular weakness—Prednisone—Crohn's disease	0.00285	0.00559	CcSEcCtD
Disopyramide—CYP3A4—digestive system—Crohn's disease	0.00283	0.0159	CbGeAlD
Disopyramide—Abdominal distension—Prednisone—Crohn's disease	0.00281	0.00552	CcSEcCtD
Disopyramide—Hypotension—Mesalazine—Crohn's disease	0.00281	0.0055	CcSEcCtD
Disopyramide—Sweating increased—Prednisone—Crohn's disease	0.00272	0.00534	CcSEcCtD
Disopyramide—Feeling abnormal—Azathioprine—Crohn's disease	0.00272	0.00533	CcSEcCtD
Disopyramide—Insomnia—Mesalazine—Crohn's disease	0.00272	0.00533	CcSEcCtD
Disopyramide—Paraesthesia—Mesalazine—Crohn's disease	0.0027	0.00529	CcSEcCtD
Disopyramide—Dyspnoea—Mesalazine—Crohn's disease	0.00268	0.00525	CcSEcCtD
Disopyramide—Somnolence—Mesalazine—Crohn's disease	0.00267	0.00524	CcSEcCtD
Disopyramide—Dyspepsia—Mesalazine—Crohn's disease	0.00264	0.00518	CcSEcCtD
Disopyramide—Neutropenia—Prednisone—Crohn's disease	0.00261	0.00512	CcSEcCtD
Disopyramide—Decreased appetite—Mesalazine—Crohn's disease	0.00261	0.00512	CcSEcCtD
Disopyramide—Body temperature increased—Azathioprine—Crohn's disease	0.00261	0.00511	CcSEcCtD
Disopyramide—Fatigue—Mesalazine—Crohn's disease	0.00259	0.00508	CcSEcCtD
Disopyramide—Erectile dysfunction—Prednisone—Crohn's disease	0.00257	0.00505	CcSEcCtD
Disopyramide—Pain—Mesalazine—Crohn's disease	0.00257	0.00504	CcSEcCtD
Disopyramide—Constipation—Mesalazine—Crohn's disease	0.00257	0.00504	CcSEcCtD
Disopyramide—Weight increased—Prednisone—Crohn's disease	0.00254	0.00499	CcSEcCtD
Disopyramide—Depression—Prednisone—Crohn's disease	0.00248	0.00487	CcSEcCtD
Disopyramide—Feeling abnormal—Mesalazine—Crohn's disease	0.00247	0.00485	CcSEcCtD
Disopyramide—Urticaria—Mesalazine—Crohn's disease	0.00239	0.00468	CcSEcCtD
Disopyramide—Body temperature increased—Mesalazine—Crohn's disease	0.00237	0.00466	CcSEcCtD
Disopyramide—Bradycardia—Prednisone—Crohn's disease	0.00228	0.00447	CcSEcCtD
Disopyramide—Diarrhoea—Azathioprine—Crohn's disease	0.00226	0.00442	CcSEcCtD
Disopyramide—Dizziness—Azathioprine—Crohn's disease	0.00218	0.00428	CcSEcCtD
Disopyramide—Asthenia—Mesalazine—Crohn's disease	0.00215	0.00423	CcSEcCtD
Disopyramide—Pruritus—Mesalazine—Crohn's disease	0.00212	0.00417	CcSEcCtD
Disopyramide—Vomiting—Azathioprine—Crohn's disease	0.0021	0.00411	CcSEcCtD
Disopyramide—Rash—Azathioprine—Crohn's disease	0.00208	0.00408	CcSEcCtD
Disopyramide—Dermatitis—Azathioprine—Crohn's disease	0.00208	0.00407	CcSEcCtD
Disopyramide—Headache—Azathioprine—Crohn's disease	0.00207	0.00405	CcSEcCtD
Disopyramide—Diarrhoea—Mesalazine—Crohn's disease	0.00205	0.00403	CcSEcCtD
Disopyramide—Arrhythmia—Prednisone—Crohn's disease	0.002	0.00392	CcSEcCtD
Disopyramide—Dizziness—Mesalazine—Crohn's disease	0.00199	0.00389	CcSEcCtD
Disopyramide—Nausea—Azathioprine—Crohn's disease	0.00196	0.00384	CcSEcCtD
Disopyramide—Vomiting—Mesalazine—Crohn's disease	0.00191	0.00374	CcSEcCtD
Disopyramide—Rash—Mesalazine—Crohn's disease	0.00189	0.00371	CcSEcCtD
Disopyramide—Dermatitis—Mesalazine—Crohn's disease	0.00189	0.00371	CcSEcCtD
Disopyramide—Headache—Mesalazine—Crohn's disease	0.00188	0.00369	CcSEcCtD
Disopyramide—Vision blurred—Prednisone—Crohn's disease	0.00183	0.0036	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisone—Crohn's disease	0.00181	0.00354	CcSEcCtD
Disopyramide—Nausea—Mesalazine—Crohn's disease	0.00178	0.0035	CcSEcCtD
Disopyramide—Angioedema—Prednisone—Crohn's disease	0.00178	0.00349	CcSEcCtD
Disopyramide—Malaise—Prednisone—Crohn's disease	0.00176	0.00344	CcSEcCtD
Disopyramide—Vertigo—Prednisone—Crohn's disease	0.00175	0.00343	CcSEcCtD
Disopyramide—Syncope—Prednisone—Crohn's disease	0.00175	0.00342	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisone—Crohn's disease	0.00171	0.00336	CcSEcCtD
Disopyramide—Discomfort—Prednisone—Crohn's disease	0.00164	0.00321	CcSEcCtD
Disopyramide—Oedema—Prednisone—Crohn's disease	0.00159	0.00312	CcSEcCtD
Disopyramide—Shock—Prednisone—Crohn's disease	0.00156	0.00307	CcSEcCtD
Disopyramide—Skin disorder—Prednisone—Crohn's disease	0.00154	0.00303	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisone—Crohn's disease	0.00154	0.00301	CcSEcCtD
Disopyramide—Anorexia—Prednisone—Crohn's disease	0.00151	0.00297	CcSEcCtD
Disopyramide—Insomnia—Prednisone—Crohn's disease	0.00144	0.00282	CcSEcCtD
Disopyramide—Paraesthesia—Prednisone—Crohn's disease	0.00143	0.0028	CcSEcCtD
Disopyramide—Dyspepsia—Prednisone—Crohn's disease	0.0014	0.00274	CcSEcCtD
Disopyramide—Decreased appetite—Prednisone—Crohn's disease	0.00138	0.00271	CcSEcCtD
Disopyramide—Fatigue—Prednisone—Crohn's disease	0.00137	0.00269	CcSEcCtD
Disopyramide—Constipation—Prednisone—Crohn's disease	0.00136	0.00266	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisone—Crohn's disease	0.00131	0.00257	CcSEcCtD
Disopyramide—Urticaria—Prednisone—Crohn's disease	0.00126	0.00248	CcSEcCtD
Disopyramide—Body temperature increased—Prednisone—Crohn's disease	0.00126	0.00246	CcSEcCtD
Disopyramide—Asthenia—Prednisone—Crohn's disease	0.00114	0.00224	CcSEcCtD
Disopyramide—Pruritus—Prednisone—Crohn's disease	0.00112	0.0022	CcSEcCtD
Disopyramide—Diarrhoea—Prednisone—Crohn's disease	0.00109	0.00213	CcSEcCtD
Disopyramide—Dizziness—Prednisone—Crohn's disease	0.00105	0.00206	CcSEcCtD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00105	0.00336	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00104	0.00333	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00103	0.0033	CbGpPWpGaD
Disopyramide—Vomiting—Prednisone—Crohn's disease	0.00101	0.00198	CcSEcCtD
Disopyramide—Rash—Prednisone—Crohn's disease	0.001	0.00196	CcSEcCtD
Disopyramide—Dermatitis—Prednisone—Crohn's disease	0.001	0.00196	CcSEcCtD
Disopyramide—Headache—Prednisone—Crohn's disease	0.000995	0.00195	CcSEcCtD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000971	0.00311	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000968	0.0031	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000961	0.00308	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000959	0.00307	CbGpPWpGaD
Disopyramide—Nausea—Prednisone—Crohn's disease	0.000944	0.00185	CcSEcCtD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000911	0.00292	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000903	0.00289	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0009	0.00288	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000891	0.00285	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000849	0.00272	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—IL6—Crohn's disease	0.000832	0.00266	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—CCR6—Crohn's disease	0.000799	0.00256	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000751	0.0024	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000748	0.0024	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000744	0.00238	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000744	0.00238	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000741	0.00237	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CCR9—Crohn's disease	0.000739	0.00237	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CCR9—Crohn's disease	0.000737	0.00236	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CCR9—Crohn's disease	0.00073	0.00234	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000704	0.00226	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000702	0.00225	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000693	0.00222	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000693	0.00222	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000693	0.00222	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—GPR65—Crohn's disease	0.000687	0.0022	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—GPR65—Crohn's disease	0.000685	0.00219	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—GPR65—Crohn's disease	0.000679	0.00217	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000664	0.00213	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000661	0.00212	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000659	0.00211	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.000653	0.00209	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000653	0.00209	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000643	0.00206	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000641	0.00205	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000635	0.00203	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00063	0.00202	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000628	0.00201	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—MLN—Crohn's disease	0.000603	0.00193	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—MLN—Crohn's disease	0.000601	0.00192	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—MLN—Crohn's disease	0.000595	0.00191	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.000578	0.00185	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ACKR2—Crohn's disease	0.000576	0.00184	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ACKR2—Crohn's disease	0.00057	0.00183	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000566	0.00181	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000565	0.00181	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000559	0.00179	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—MLN—Crohn's disease	0.000548	0.00175	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—MLN—Crohn's disease	0.000546	0.00175	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—MLN—Crohn's disease	0.00054	0.00173	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000524	0.00168	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000493	0.00158	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00049	0.00157	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	0.000488	0.00156	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000488	0.00156	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—SMAD3—Crohn's disease	0.000485	0.00155	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	0.000484	0.00155	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000482	0.00154	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000463	0.00148	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—TYK2—Crohn's disease	0.000443	0.00142	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000432	0.00138	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000431	0.00138	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.00043	0.00138	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.000426	0.00136	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—JAK2—Crohn's disease	0.000423	0.00135	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000418	0.00134	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.000417	0.00133	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.000413	0.00132	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	0.00041	0.00131	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000389	0.00125	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000389	0.00124	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.000387	0.00124	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.000384	0.00123	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	0.000382	0.00122	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000379	0.00121	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.000378	0.00121	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.000375	0.0012	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000357	0.00114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000353	0.00113	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.000353	0.00113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000352	0.00113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.000348	0.00111	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MTMR3—Crohn's disease	0.000348	0.00111	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000343	0.0011	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000341	0.00109	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.00034	0.00109	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.000337	0.00108	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000328	0.00105	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MTMR3—Crohn's disease	0.000325	0.00104	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.000323	0.00104	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.000322	0.00103	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000322	0.00103	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00032	0.00103	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.000319	0.00102	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TYK2—Crohn's disease	0.000316	0.00101	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000307	0.000982	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000306	0.000979	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000306	0.000979	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—JAK2—Crohn's disease	0.000302	0.000966	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MTMR3—Crohn's disease	0.0003	0.00096	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000296	0.000947	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.000295	0.000944	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.000292	0.000935	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000277	0.000886	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.000276	0.000883	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.000273	0.000875	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—FADS1—Crohn's disease	0.000271	0.000869	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000259	0.000828	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000258	0.000825	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000257	0.000824	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.000255	0.000817	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GPX4—Crohn's disease	0.000254	0.000813	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—FADS1—Crohn's disease	0.000253	0.00081	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000251	0.000805	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000251	0.000802	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000249	0.000796	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000248	0.000794	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GCKR—Crohn's disease	0.000245	0.000785	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000245	0.000785	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000244	0.000782	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000244	0.00078	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000243	0.000778	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000242	0.000775	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000241	0.00077	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GPX4—Crohn's disease	0.000237	0.000758	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—FADS1—Crohn's disease	0.000234	0.000748	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GCKR—Crohn's disease	0.000229	0.000732	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.000224	0.000718	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000223	0.000715	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—STAT3—Crohn's disease	0.000221	0.000709	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000221	0.000708	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.000221	0.000708	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.000221	0.000706	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GPX4—Crohn's disease	0.000219	0.0007	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000218	0.000699	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—IL6—Crohn's disease	0.000217	0.000694	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GCKR—Crohn's disease	0.000211	0.000676	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000208	0.000667	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000208	0.000665	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000208	0.000665	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000207	0.000664	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.000207	0.000662	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000207	0.000661	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000206	0.000659	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000205	0.000656	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000205	0.000655	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000201	0.000643	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000201	0.000642	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.0002	0.000641	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000198	0.000634	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TNF—Crohn's disease	0.000192	0.000614	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.000189	0.000603	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.000188	0.000602	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000186	0.000596	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000182	0.000584	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000182	0.000582	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.00018	0.000576	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000167	0.000534	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.000166	0.000531	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000158	0.000505	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.000157	0.000504	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000157	0.000503	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000157	0.000502	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000156	0.000499	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000155	0.000497	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—IL6—Crohn's disease	0.000155	0.000495	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.000149	0.000475	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.000148	0.000474	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000147	0.000469	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000145	0.000466	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000145	0.000464	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000144	0.00046	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000138	0.000441	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000134	0.00043	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000134	0.000429	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.000133	0.000424	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000132	0.000423	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000132	0.000421	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000131	0.000419	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.00013	0.000417	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.00013	0.000417	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000129	0.000413	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000118	0.000377	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000117	0.000376	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000117	0.000375	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000116	0.000372	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000114	0.000366	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000114	0.000364	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000113	0.000361	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000111	0.000356	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000111	0.000355	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.00011	0.000352	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000108	0.000345	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000107	0.000344	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000106	0.00034	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	9.77e-05	0.000313	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	9.76e-05	0.000312	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	9.74e-05	0.000312	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	9.73e-05	0.000311	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	9.65e-05	0.000309	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	9.63e-05	0.000308	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	9.3e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	9.27e-05	0.000297	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	9.18e-05	0.000294	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—FADS1—Crohn's disease	9.13e-05	0.000292	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	8.92e-05	0.000286	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	8.89e-05	0.000285	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	8.88e-05	0.000284	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	8.85e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	8.81e-05	0.000282	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	8.76e-05	0.00028	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX4—Crohn's disease	8.55e-05	0.000274	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	8.42e-05	0.00027	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	8.4e-05	0.000269	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	8.32e-05	0.000266	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCKR—Crohn's disease	8.26e-05	0.000264	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	8.1e-05	0.000259	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	8.08e-05	0.000258	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	8e-05	0.000256	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—Crohn's disease	7.81e-05	0.00025	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	7.8e-05	0.00025	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	7.78e-05	0.000249	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	7.7e-05	0.000247	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—Crohn's disease	7.28e-05	0.000233	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—Crohn's disease	6.83e-05	0.000219	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—Crohn's disease	6.72e-05	0.000215	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—Crohn's disease	6.37e-05	0.000204	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—Crohn's disease	5.88e-05	0.000188	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TYK2—Crohn's disease	5.5e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TYK2—Crohn's disease	5.48e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TYK2—Crohn's disease	5.43e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JAK2—Crohn's disease	5.24e-05	0.000168	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JAK2—Crohn's disease	5.23e-05	0.000167	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JAK2—Crohn's disease	5.18e-05	0.000166	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	4.79e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	4.77e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	4.72e-05	0.000151	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—Crohn's disease	4.55e-05	0.000146	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—Crohn's disease	4.54e-05	0.000145	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—Crohn's disease	4.49e-05	0.000144	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STAT3—Crohn's disease	3.85e-05	0.000123	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STAT3—Crohn's disease	3.84e-05	0.000123	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STAT3—Crohn's disease	3.8e-05	0.000122	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—Crohn's disease	2.69e-05	8.61e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—Crohn's disease	2.68e-05	8.58e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—Crohn's disease	2.65e-05	8.49e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—Crohn's disease	2.63e-05	8.41e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.3e-05	7.36e-05	CbGpPWpGaD
